-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
INVO Bioscience, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2011 to 2023.
- INVO Bioscience, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$1.9M, a 7.89% increase year-over-year.
- INVO Bioscience, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$5.24M, a 45.5% increase year-over-year.
- INVO Bioscience, Inc. annual Operating Income (Loss) for 2023 was -$6.77M, a 36.3% increase from 2022.
- INVO Bioscience, Inc. annual Operating Income (Loss) for 2022 was -$10.6M, a 104% decline from 2021.
- INVO Bioscience, Inc. annual Operating Income (Loss) for 2021 was -$5.22M, a 5.41% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)